Order Article Reprints

Varghese FS, van Woudenbergh E, Overheul GJ, Eleveld MJ, Kurver L, van Heerbeek N, van Laarhoven A, Miesen P, den Hartog G, de Jonge MI, et al. Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro. Viruses. 2021; 13(2):282. https://doi.org/10.3390/v13020282

Varghese, Finny S., Esther van Woudenbergh, Gijs J. Overheul, Marc J. Eleveld, Lisa Kurver, Niels van Heerbeek, Arjan van Laarhoven, Pascal Miesen, Gerco den Hartog, Marien I. de Jonge, and et al. 2021. "Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro" Viruses 13, no. 2: 282. https://doi.org/10.3390/v13020282

Varghese, F. S., van Woudenbergh, E., Overheul, G. J., Eleveld, M. J., Kurver, L., van Heerbeek, N., van Laarhoven, A., Miesen, P., den Hartog, G., de Jonge, M. I., & van Rij, R. P. (2021). Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro. Viruses, 13(2), 282. https://doi.org/10.3390/v13020282